Central Nervous System Control of Glucose Homeostasis: A Therapeutic Target for Type 2 Diabetes?

Mirzadeh, Zaman; Faber, Chelsea L; Schwartz, Michael W

Mirzadeh, Zaman; Faber, Chelsea L; Schwartz, Michael W.

Afiliación

Mirzadeh Z; Ivy Brain Tumor Center, Department of Neurosurgery, Barrow Neurological Institute, Phoenix, Arizona 85013, USA; email: zaman.mirzadeh@barrowneuro.org.
Faber CL; Ivy Brain Tumor Center, Department of Neurosurgery, Barrow Neurological Institute, Phoenix, Arizona 85013, USA; email: zaman.mirzadeh@barrowneuro.org.
Schwartz MW; UW Medicine Diabetes Institute, Department of Medicine, University of Washington, Seattle, Washington 98109, USA; email: mschwart@uw.edu.

Annu Rev Pharmacol Toxicol ; 62: 55-84, 2022 01 06.

Article en En | MEDLINE | ID: mdl-34990204

Asunto(s)

Diabetes Mellitus Tipo 2; Sistema Nervioso Central; Diabetes Mellitus Tipo 2/tratamiento farmacológico; Glucosa; Homeostasis; Humanos; Insulina

Palabras clave

autonomic nervous system; central nervous system; diabetes; glucose effectiveness; glucose homeostasis; insulin-independent glucose disposal; therapeutics

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 2 Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Annu Rev Pharmacol Toxicol Año: 2022 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google